The production plant in Parma covers a total area of more than fifteen thousand square metres, and it is the strategic hub for the production and distribution of our products, an international supply centre that exports to more than 80 countries.
The Parma plant produces solid form medicinal products, such as tablets and dry powder inhalers; solutions and suspensions for inhalation, either pressurised or sterile single-dose vials; vials of sterile suspension for endotracheal administration; liquid forms such as drops, syrups and nasal sprays.
The plant has been successfully inspected several times by regulatory authorities from a number of countries: the U.S. Food and Drug Administration, the Canadian Therapeutic Products Program, the Chinese CFDA, Russian GMP & Quality Management Inspectorate, the Brazilian Health Agency ANVISA and the Italian AIFA (Italian Agency for Pharmaceuticals). A Health and Work Safety Management System complying with OHSAS 18001 standard, an Environment Management system in accordance with ISO 14001 and a Quality Management system in accordance with ISO 9001 are in place and has been certified.
More then 530 people work at the production plant of Parma.